Cancer Clinical Trial Eligibility Criteria: Washout Periods and Concomitant Medications; Guidance for Industry, Institutional Review Boards, and Clinical Investigators; Availability
FDA_FRDOC_0001-14376Notice
Document
Details
The document's own metadata, straight from the source system.
- Title
- Cancer Clinical Trial Eligibility Criteria: Washout Periods and Concomitant Medications; Guidance for Industry, Institutional Review Boards, and Clinical Investigators; Availability
- Posted
- Jul 28, 2026
- FR Doc
- 2026-15186
- Topics